| Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases DE McMahon, E Amerson, M Rosenbach, JB Lipoff, D Moustafa, A Tyagi, ... Journal of the American Academy of Dermatology 85 (1), 46-55, 2021 | 844 | 2021 |
| The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool MA Judson, U Costabel, M Drent, A Wells, L Maier, L Koth, H Shigemitsu, ... Sarcoidosis Vasc Diffuse Lung Dis 31 (1), 19-27, 2014 | 460 | 2014 |
| The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries EE Freeman, DE McMahon, JB Lipoff, M Rosenbach, C Kovarik, SR Desai, ... Journal of the American academy of dermatology 83 (4), 1118-1129, 2020 | 428 | 2020 |
| Reliability and convergent validity of two outcome instruments for pemphigus M Rosenbach, DF Murrell, JC Bystryn, S Dulay, S Dick, S Fakharzadeh, ... Journal of investigative dermatology 129 (10), 2404-2410, 2009 | 240 | 2009 |
| Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries EE Freeman, DE McMahon, JB Lipoff, M Rosenbach, C Kovarik, ... Journal of the American Academy of Dermatology 83 (2), 486-492, 2020 | 235 | 2020 |
| Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation M Rosenbach, S Hsu, NJ Korman, MG Lebwohl, M Young, BF Bebo Jr, ... Journal of the American Academy of Dermatology 62 (4), 655-662, 2010 | 230 | 2010 |
| Prevention and management of glucocorticoid-induced side effects: a comprehensive review: a review of glucocorticoid pharmacology and bone health A Caplan, N Fett, M Rosenbach, VP Werth, RG Micheletti Journal of the American Academy of Dermatology 76 (1), 1-9, 2017 | 196 | 2017 |
| Granuloma annulare: clinical and histologic variants, epidemiology, and genetics EW Piette, M Rosenbach Journal of the American Academy of Dermatology 75 (3), 457-465, 2016 | 180 | 2016 |
| Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study EY Chu, KA Wanat, CJ Miller, RK Amaravadi, LA Fecher, MS Brose, ... Journal of the American Academy of Dermatology 67 (6), 1265-1272, 2012 | 180 | 2012 |
| Neutrophilic dermatoses: pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease CA Nelson, S Stephen, HJ Ashchyan, WD James, RG Micheletti, ... Journal of the American Academy of Dermatology 79 (6), 987-1006, 2018 | 173 | 2018 |
| SJS/TEN 2017: building multidisciplinary networks to drive science and translation KD White, R Abe, M Ardern-Jones, T Beachkofsky, C Bouchard, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (1), 38-69, 2018 | 173 | 2018 |
| The association of age with clinical presentation and comorbidities of pyoderma gangrenosum HJ Ashchyan, DC Butler, CA Nelson, MH Noe, WG Tsiaras, SJ Lockwood, ... JAMA dermatology 154 (4), 409-413, 2018 | 163 | 2018 |
| Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options EW Piette, M Rosenbach Journal of the American Academy of Dermatology 75 (3), 467-479, 2016 | 155 | 2016 |
| Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study DE McMahon, CL Kovarik, W Damsky, M Rosenbach, JB Lipoff, A Tyagi, ... Journal of the American Academy of Dermatology 86 (1), 113-121, 2022 | 149 | 2022 |
| HLA-A* 32: 01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms KC Konvinse, JA Trubiano, R Pavlos, I James, CM Shaffer, CA Bejan, ... Journal of allergy and clinical immunology 144 (1), 183-192, 2019 | 148 | 2019 |
| Long COVID in the skin: a registry analysis of COVID-19 dermatological duration DE McMahon, AE Gallman, GJ Hruza, M Rosenbach, JB Lipoff, SR Desai, ... The Lancet Infectious Diseases 21 (3), 313-314, 2021 | 137 | 2021 |
| Reactive granulomatous dermatitis: a review of palisaded neutrophilic and granulomatous dermatitis, interstitial granulomatous dermatitis, interstitial granulomatous drug … M Rosenbach, JC English Dermatologic Clinics 33 (3), 373-387, 2015 | 137 | 2015 |
| Tumor necrosis factor inhibitor–associated dermatomyositis R Klein, M Rosenbach, EJ Kim, B Kim, VP Werth, J Dunham Archives of dermatology 146 (7), 780-784, 2010 | 127 | 2010 |
| Stevens-Johnson syndrome/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States RG Micheletti, Z Chiesa-Fuxench, MH Noe, S Stephen, M Aleshin, ... Journal of Investigative Dermatology 138 (11), 2315-2321, 2018 | 120 | 2018 |
| Cutaneous sarcoidosis KA Wanat, M Rosenbach Clinics in chest medicine 36 (4), 685-702, 2015 | 119 | 2015 |
